Align Technology | ALGN - Sales Revenues

Stock Price
195.28
Daily Change
3.62 1.89%
Monthly
7.97%
Yearly
12.31%
Q2 Forecast
185.89

Align Technology reported $1.05B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
3M USD 6B 100M Mar/2026
Align Technology USD 1.05B 54.3M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Cardinal Health USD 65.63B 1.63B Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
CVS Health USD 105.7B 2.8B Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 961M 57M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Masimo USD 412.5M 41M Dec/2025
McKesson USD 106.16B 3.01B Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Solventum Corp USD 1.99B 110M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Veeva Systems USD 835.95M 24.72M Dec/2025
Waters USD 932M 132M Dec/2025
Zimmer Biomet Holdings USD 2.24B 240M Dec/2025
Zoetis USD 2.4B 0 Dec/2025